Category: News

Toronto, Ontario–(Newsfile Corp. – April 27, 2021) – The Hash Corporation (the “Company“, or “HashCo“), a Canadian company positioning itself to focus on the production and sale of cannabis-based hashish and other cannabis products, is pleased to announce that it has entered into a product acquisition agreement (the “Agreement“) with Canada House Wellness Group (CSE: CHV) (“Canada House“) and its wholly owned subsidiary, Abba Medix Corp., a licensed cultivator and processor under the Cannabis Act (“Abba“).

Under the terms of the Agreement, HashCo will sell certain cannabis materials comprised of pressed dry sift hash to Abba, through the Company’s collaboration agreement with Medz Cannabis Inc., a licensed cultivator and processor under the Cannabis Act. Upon Abba’s successful listing of purchased hash materials for sale in Quebec, the Agreement will commence and will remain in effect for a period of 12 months with the option to renew for subsequent 12 month periods.

“HashCo is extremely excited to enter into this relationship with the wonderful teams at Canada House and Abba,” commented Chris Savoie, CEO of Hashco. “This Agreement allows Hashco to leverage Abba’s established distribution channels to bring its high-quality products to hash consumers throughout the Province of Quebec.”

About The Hash Corporation

HashCo is a Canadian company positioning itself to focus on the production and sale of cannabis-based hashish and other cannabis products. HashCo intends to apply its separation and curing techniques to produce a suite of high-quality cannabis resin products, which are all-natural and free of additives and carcinogenic solvents. The Company intends to tailor its product offerings to pay tribute to historic traditions, fragrances and tastes, while upholding the highest health and safety standards.

As of the date of this press release, HashCo is actively seeking and developing partnerships and collaborations with licensed cultivators and other strategic partners within Canada, with the goal of crafting and introducing to the regulated market authentic products which reflect quality and innovation.

About Canada House Wellness Group

Canada House Wellness Group is the parent company of Abba Medix Corp., a Licensed Producer in Pickering, Ontario that produces high quality medical grade cannabis; IsoCanMed Inc., a Licensed Producer in Louiseville, Québec growing best-in-class indoor cannabis, in its 64,000 sq. ft. production facility employing state-of-the-art vertical, aeroponic production methodologies; Canada House Clinics Inc., with clinics across the country that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions; and Knalysis Technologies, a provider of fully customizable, cloud-based software that links physician, provider, and patient to data that supports treatment with medical cannabis.

Canada House Wellness Group’s goal is to become the leading cultivator of premium craft cannabis and provider of cannabinoid therapy, targeting the medical cannabis markets globally.

For additional information on The Hash Corporation:
Chris Savoie
The Hash Corporation, Chief Executive Officer
1800-420-REZN
chris@hashco.ca
www.thehashcorporation.com

Forward Looking Information

Certain statements in this press release may constitute “forward looking statements” which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. When used in this press release, such statements may use such words as “may”, “will”, “expect”, “believe”, “plan” and other similar terminology. Such statements reflect management’s current expectations regarding future events and speak only as of the date of this press release. The forward-looking statements involve a number of risks and uncertainties, including, but not limited to, the Company’s stage of development, capital requirements and future ability to fund operations, regulatory requirements, general economic, and market or business conditions, and the Company’s ability to carry out its obligations under the Agreement. The forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance, or achievements that may be expressed or implied by such forward-looking statements. In making the forward-looking statements included in this release, the Company has made various material assumptions, including, but not limited to: obtaining regulatory approvals, general business and economic conditions, the Company’s ability to successfully carry out of all its obligations under the Agreement on the terms set out in the Agreement, the purchasers’ ability to obtain approval from the Société québécoise du cannabis, the purchasers’ willingness to carry out the terms of the Agreement and purchase the Product, the Company’s ability to maintain good relationships with its partners and other third parties, market competition, and the immediate and eventual impacts of Coronavirus Disease 2019 (COVID-19) on the Company’s proposed operations and financial condition, and market demand. The foregoing list of factors is not exhaustive. The Company undertakes no obligation to update publicly or revise any forward-looking statements, whether a result of new information, future results or otherwise, except as required by law. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking-information. The foregoing statements expressly qualify any forward-looking information contained herein.

NOT FOR DISSEMINATION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

https://www.newsfilecorp.com/release/81974

Toronto, Ontario–(March 18, 2021) – The Hash Corporation (the “Company“) is pleased to announce that it has completed a non-brokered private placement for gross proceeds of $1,505,000.00 (the “Financing“) through the issuance of 15,050,000 common shares (“Shares“) of the Company at a price of $0.10 per Share. The Financing closed on March 15, 2021.

First Republic Capital Corporation acted as the lead finder for the Financing. The Company paid a cash commission to eligible finders equal to 6% of the gross proceeds raised, and paid a corporate finance fee equal to an additional 4% of gross proceeds. The Company also issued compensation warrants equal to 6% of the Shares sold under the Financing, and corporate finance warrants equal to 4% of the Shares sold under the Financing, each being exercisable into one (1) Share at a price of $0.10 per Share for a period of 24 months from the date of issuance thereof.

All securities issued in connection with the Financing are subject to a four-month hold period from the date of issuance in accordance with applicable securities laws.

For additional information on The Hash Corporation:

Christopher Savoie, CEO
Phone: (416) 371-3697

Cautionary Notes

Certain statements in this press release may constitute “forward-looking statements” which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. When used in this press release, such statements may use such words as “may”, “will”, “expect”, “believe”, “plan” and other similar terminology. Such statements reflect management’s current expectations regarding future events and speak only as of the date of this press release. The forward-looking statements involve a number of risks and uncertainties. These risks and uncertainties include, but are not limited to, the Company’s stage of development, capital requirements and future ability to fund operations, regulatory requirements, general economic, and market or business conditions. The foregoing list of factors is not exhaustive. The Company undertakes no obligation to update publicly or revise any forward-looking statements, whether a result of new information, future results or otherwise, except as required by law.

NOT FOR DISSEMINATION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

https://www.newsfilecorp.com/release/77774/The-Hash-Corporation-Announces-Closing-of-Private-Placement

Toronto, Ontario–(March 2, 2021) – The Hash Corporation (the “Company“, or “HashCo“), a Canadian company positioning itself to focus on the production and sale of cannabis-based hashish and other cannabis products, is pleased to announce that it has entered into a long-term collaboration agreement (the “Collaboration Agreement“) with Black Rose Organics Canada Inc. (“Black Rose“), an Ontario-based, privately-owned company licensed for the cultivation, processing and sale of cannabis under the Cannabis Act.

Under the terms of the Collaboration Agreement, Black Rose will provide the Company with up to 1,000 square feet of processing space (the “Processing Space“) within a licensed facility owned by Black Rose and located in Markham, Ontario (the “Facility“), to manufacture and distribute cannabis-based hashish and other cannabis concentrates (collectively, the “Products“). In addition, Black Rose will assist the Company in obtaining the requisite regulatory approvals to produce and sell the Products and make use of the Processing Space, and supply the Company with cannabis bi-products and biomass required by the Company to produce the Products. Under the terms of the Collaboration Agreement, the Company and Black Rose will share profits 50/50 on sales of Products at channels established by Black Rose for the Company, on sales of Products cultivated and/or branded by Black Rose, and on all tolling services provided by the Company at the Facility.

About The Hash Corporation

HashCo is a Canadian company positioning itself to focus on the production and sale of cannabis-based hashish and other cannabis products. HashCo intends to apply its separation and curing techniques to produce a suite of high-quality cannabis resin products, which are all-natural and free of additives and carcinogenic solvents. The Company intends to tailor its product offerings to pay tribute to historic traditions, fragrances and tastes, while upholding the highest health and safety standards.

As of the date of this press release, HashCo is actively seeking and developing partnerships and collaborations with licensed cultivators and other strategic partners within Canada, with the goal of crafting and introducing to the regulated market authentic products which reflect quality and innovation.

About Black Rose

Black Rose is a medicinal licensed producer founded in Toronto, Canada, with a dedicated focus on establishing a world class, craft level quality product base for the medicinal community. Using the most innovative and efficient growing techniques available, Black Rose is situating itself to redefine the level of quality standards expected in both the Canadian and international markets. Black Rose intends to establish their organic and non-organic cannabis product lines adhering to the highest standards available, through proven processes with a focused attention to detail at every step.

Through strategic partnerships with reputable licensed cannabis companies in the industry, Black Rose Organics vision is to consistently elevate the standards of quality within the regulated market, and intends to do so by using the safest and most effective processes available.

For additional information on The Hash Corporation:
Chris Savoie
The Hash Corporation, Chief Executive Officer
416-371-3697
chris@hashco.ca
www.thehashcorporation.com

Forward Looking Information

Certain statements in this press release may constitute “forward looking statements” which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. When used in this press release, such statements may use such words as “may”, “will”, “expect”, “believe”, “plan” and other similar terminology. Such statements reflect management’s current expectations regarding future events and speak only as of the date of this press release. The forward-looking statements involve a number of risks and uncertainties, including, but not limited to, the Company’s stage of development, capital requirements and future ability to fund operations, regulatory requirements, general economic, and market or business conditions. The forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance, or achievements that may be expressed or implied by such forward-looking statements. In making the forward-looking statements included in this release, the Company has made various material assumptions, including, but not limited to: obtaining regulatory approvals, general business and economic conditions, the Company’s ability to successfully secure and make use of the Processing Space and process, market and sell its products, the Company’s ability to maintain good relationships with its partners and other third parties, market competition, and the immediate and eventual impacts of Coronavirus Disease 2019 (COVID-19) on the Company’s proposed operations and financial condition, and market demand. The foregoing list of factors is not exhaustive. The Company undertakes no obligation to update publicly or revise any forward-looking statements, whether a result of new information, future results or otherwise, except as required by law. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking-information. The foregoing statements expressly qualify any forward-looking information contained herein.

NOT FOR DISSEMINATION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

https://www.newsfilecorp.com/release/75867/The-Hash-Corporation-Enters-into-Collaboration-Agreement-with-Black-Rose-Organics-Canada-Inc.

The Hash Corporation Announces Closing of Private Placement Toronto, ON – January 6, 2020 – The Hash Corporation (the “Company”) is pleased to announce that it has completed a non-brokered private placement for gross proceeds of $1,036,000 (the “Financing”) through the issuance of 20,720,000 common shares (“Shares”) of the Company at a price of $0.05 per Share.

The Financing closed in tranches of $929,000 and $107,000 on November 4, 2019 and December 23, 2019, respectively. First Republic Capital Corporation acted as the lead finder for the Financing. The Company paid a cash commission to eligible finders equal to 6% of the gross proceeds raised, and paid a corporate finance fee equal to an additional 4% of gross proceeds. The Company also issued compensation warrants equal to 6% of the Shares sold under the Financing, and corporate finance warrants equal to 4% of the Shares sold under the Financing, each being exercisable into one (1) Share at a price of $0.05 per Share for a period of 24 months from the date of issuance thereof. All securities issued in connection with the Financing are subject to a four-month hold period from the date of issuance in accordance with applicable securities laws.

For additional information on The Hash Corporation:

Chris Savoie, CEO
Phone: (416) 371-3697

Cautionary Notes

Certain statements in this press release may constitute “forward looking statements” which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. When used in this press release, such statements may use such words as “may”, “will”, “expect”, “believe”, “plan” and other similar terminology. Such statements reflect management’s current expectations regarding future events and speak only as of the date of this press release. The forward-looking statements involve a number of risks and uncertainties. These risks and uncertainties include, but are not limited to, the Company’s stage of development, capital requirements and future ability to fund operations, regulatory requirements, general economic, and market or business conditions. The foregoing list of factors is not exhaustive. The Company undertakes no obligation to update publicly or revise any forward-looking statements, whether a result of new information, future results or otherwise, except as required by law.

NOT FOR DISSEMINATION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Toronto, Ontario–(Newsfile Corp. – August 30, 2019) – The Hash Corporation (formerly, Senternet Phi Gamma Inc.) (“HashCo” or the “Company“) is pleased to announce that it has completed a non-brokered private placement financing (the “Financing“) as previously announced on July 5, 2019, and increased the Financing from $1,500,000 to $2,166,514.64. Pursuant to the Financing, the Company issued 108,325,732 common shares of the Company at a price of $0.02 per Share.

All securities issued in connection with the Financing are subject to a four-month hold period from the date of issuance in accordance with applicable securities laws. A portion of the Financing constitutes a “related party transaction” under Multilateral Instrument 61-101 (“MI 61-101”) as officers and directors of the Company participated in the Financing. The Financing is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101, as neither the fair market value of securities being issued to insiders nor the consideration being paid by insiders will exceed 25% of the Company’s market capitalization. The Company did not file a material change report 21 days prior to the closing of the Financing as the details of the participation of the related parties of the Company had not been confirmed at that time.

First Republic Capital Corporation (“First Republic“) acted as the lead finder for the Financing. A cash fee was paid to finders representing 6% of the gross proceeds raised in the Financing. Additionally, finders received that number of compensation warrants (“Compensation Warrants“) totaling 6% of the number of Shares sold pursuant to the Financing. The Compensation Warrants are exercisable at a price of $0.02 per share for a period of 24 months after the closing of the Financing. First Republic was paid a corporate finance fee representing 4% of the gross proceeds raised in the Financing and that number of Compensation Warrants equaling 4% of the number of shares sold in the Financing.

In addition, the Company is pleased to announce that, effective immediately, it has appointed Michael Syme as Vice-President of Production and Shimmy Posen as Corporate Secretary. Yaron Conforti has resigned as Secretary effective immediately, but will remain on the board of directors.

For additional information on The Hash Corporation:

Chris Savoie, CEO
Phone: (416) 371-3697

Cautionary Notes

Certain statements in this press release may constitute “forward looking statements” which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. When used in this press release, such statements may use such words as “may”, “will”, “expect”, “believe”, “plan” and other similar terminology. Such statements reflect management’s current expectations regarding future events and speak only as of the date of this press release. The forward-looking statements involve a number of risks and uncertainties. These risks and uncertainties include, but are not limited to, the Company’s stage of development, capital requirements and future ability to fund operations, regulatory requirements, general economic, and market or business conditions. The foregoing list of factors is not exhaustive. The Company undertakes no obligation to update publicly or revise any forward-looking statements, whether a result of new information, future results or otherwise, except as required by law.

NOT FOR DISSEMINATION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

https://www.newsfilecorp.com/release/47425/The-Hash-Corporation-Announces-Closing-of-Oversubscribed-Private-Placement-Financing

Toronto, Ontario–(Newsfile Corp. – July 5, 2019) – Senternet Phi Gamma Inc. (“Senternet” or the “Company“) is pleased to announce that, subject to receipt of all required licences and to Health Canada approval for the sale of such products, the Company intends to change its business to focus on the production and sale of cannabis-based hashish and other cannabis concentrates (the “Change of Business“). Further to the proposed Change of Business, the Company intends to effect a series of related transactions designed to better align itself with the new business.

Change of Business

As part of the Change of Business, the Company intends to effect a series of transactions on or about July 8, 2019, including:

1. changing its name from “Senternet Phi Gamma Inc.” to “The Hash Corporation” (the “Name Change“);
2. effecting a consolidation (the “Consolidation“) of its issued and outstanding common on the basis of one post-consolidation common share for every 20 pre-consolidation common shares (each post-consolidation common share, a “Post-Consolidation Share“); and
3. reconstituting the Company’s board of directors and senior officers, such that it consists of Chris Savoie (Chief Executive Officer and Director), Ty Metford (Chief Operating Officer), Donal Carroll (Chief Financial Officer), Jesse Kline (Chief Communications Officer), Yaron Conforti (Director), Binyomin Posen (Director), Jesse Kaplan (Director) and Sruli Weinreb (Director) (the “Board and Management Rollover“).

Following the Name Change, Consolidation, and Board and Management Rollover (collectively, the “COB Items“), the Company (as it exists following the COB Items, the “Resulting Issuer“) intends to effect a private placement of Post-Consolidation Shares at a price of $0.02 per share for gross proceeds of up to $1,500,000, or such greater number as the Resulting Issuer may determine (the “Offering“). In connection with the Offering, the Resulting Issuer may pay commissions to eligible persons comprised of cash and finder warrants.

In addition, the Resulting Issuer intends to grant 100,000,000 special warrants to an arm’s length consultant, each special warrant entitling the holder thereof to acquire one Post-Consolidation at a nominal purchase price for a period of one year (the “Special Warrant Grants“). The special warrants will vest upon the satisfaction by the consultant of certain prescribed milestones.

Warrant Extension

In addition, the Company announces that it has extended the expiration date of the warrants issued in the Company’s private placement that closed on May 4, 2018, with the new expiration date being the date that is three months following the date on which the Company’s common shares are listed on a recognized stock exchange.

For additional information on Senternet Phi Gamma Inc.:

Yaron Conforti
CEO, CFO, Secretary and Director
Phone: (416) 716-8181

Forward-Looking Statements

This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to: the terms and conditions of the proposed Change of Business; the terms and conditions of the proposed Offering, Consolidation, Name Change, use of funds; and the business and operations of the Resulting Issuer after the proposed Change of Business. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Risk factors that could cause actual results or outcomes to differ materially from the results expressed or implied by forward-looking information include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; changes in tax laws, general economic and business conditions; and the ability of the Resulting Issuer to execute and achieve its business objectives. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company cautions the reader that the above list of risk factors is not exhaustive. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

https://www.newsfilecorp.com/release/46107/Senternet-Announces-Proposed-Change-of-Business